iMDsoft's Decision Support Tools Help Dramatically Reduce Errors, Improve Protocol Compliance and Enhance Financial Performance

iMDsoftiMDsoft®'s Clinical Information Systems, coupled with MetaVision Event ManagerTM, are proven to significantly improve care quality and efficiency, to increase adherence to regulations and protocols and to deliver financial benefits. Hospitals using iMDsoft's products have reported outcomes that include increased revenue, reduced prescription errors and adverse events, improved nutrition in the ICU and increased adherence with PONV guidelines, PQRI measures and organ donation guidelines.

MetaVision Event Manager from iMDsoft is a decision support tool that uses branching, longitudinal logic to track changes in patient status and deviations from clinical or administrative protocols. Event Manager issues smart notifications when specific changes in a patient's condition are detected, enabling timely clinical responses. It sends on-screen, email, or SMS reminders for required actions such as initiating or discontinuing medications, performing tests, or taking recommended safety measures. Event Manager can also help contain costs by presenting clinicians with valuable opportunities to make fiscally responsible decisions.

The following research highlights the high impact results hospitals have achieved using MetaVision®’s decision support tools:

Schneider Children's Medical Center, Israel:
MetaVision prevents weight-based calculation errors, which are of particular significance in pediatrics. Adverse drug events were reduced by 72%, while medication prescription errors fell from 5.5% to a mere 0.7% (Pediatrics, Vol. 124, No. 3, September 2009, pp. 935-940).

VU University Medical Center, the Netherlands:
MetaVision allows for improved early delivery of nutrition in the ICU. Using Event Manager, the percentage of patients with adequate nutrients delivered by day 4 in the ICU increased from 30.2% to 56.5%, in accordance with ICU guidelines (The Netherlands Journal of Medicine, Vol. 67, No. 11, December 2009).

OLVG hospital, the Netherlands:
MetaVision dramatically increases adherence to prophylaxis administration guidelines. Timely delivery of both dexamethasone and granisetron increased from 39% to 79% (European Journal of Anaesthesiology, Vol 27 - Issue 2 pp. 187–191 February 2010).

Henry Ford Hospital, US:
MetaVision dramatically improves regulatory compliance, increasing organ donation conversion rate from 64% to 86%. Event Manager enabled the hospital to comfortably exceed the CMS and Joint Commission national goal of 75%.

Massachusetts General Hospital (MGH), US:
MGH implemented an extensive research and education program exploring the safety and effectiveness of drug alternatives (higher vs. lower cost). After MGH set up prompts using Event Manager for drug optimization during long surgeries, the program saved the hospital $700,000 over a period of 16 months.

Lehigh Valley Hospital (LVH), US:
MetaVision significantly enhances compliance with PQRI Measure 193 - Perioperative Temperature Management, designed to reduce the incidence of perioperative hypothermia. Compliance has increased from 60% to 92% since LVH implemented MetaVision Event Manager.

"Given the growing complexity of regulations and clinical workflow, hospitals need advanced clinical information systems that feature powerful decision support tools," said Phyllis Gotlib, CEO, iMDsoft. "iMDsoft clients all over the world report concrete, quantifiable improvements in patient safety, adherence to clinical and administrative protocols, and better financial performance."

About iMDsoft
iMDsoft is a leading provider of Clinical Information Systems (CIS) for perioperative, critical, and acute care. The company's flagship family of solutions, the MetaVision Suite, was first implemented in 1999. It has since become a market leader, with implementations in a wide range of ICUs, ORs, and general wards. iMDsoft products demonstrate a 100% customer retention rate and 100% implementation success rate. Major medical centers across the US, Europe, Asia, and Australia use iMDsoft's technology to improve care quality, promote patient safety, enhance financial performance, support research and compliance, and achieve sustainable market leadership. To learn more, visit www.imd-soft.com.

Most Popular Now

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...